BSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
NSE Live
Apr 09, 15:51Prev. Close
1.51
Open Price
1.58
Bid Price (Qty.)
22.10 (1)
Offer Price (Qty.)
22.45 (200)
| Balance Sheet of Vaxtex Cotfab (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 6.02 | 0.40 | 0.40 | 0.40 | 0.40 | |
| Total Share Capital | 6.02 | 0.40 | 0.40 | 0.40 | 0.40 | |
| Reserves and Surplus | 2.63 | 4.33 | 3.72 | 3.55 | 3.53 | |
| Total Reserves and Surplus | 2.63 | 4.33 | 3.72 | 3.55 | 3.53 | |
| Total Shareholders Funds | 8.65 | 4.73 | 4.13 | 3.96 | 3.94 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 9.27 | 2.91 | 0.21 | 0.00 | 0.00 | |
| Deferred Tax Liabilities [Net] | 0.14 | 0.10 | 0.06 | 0.01 | 0.00 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 9.41 | 3.00 | 0.27 | 0.01 | 0.00 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 3.34 | 0.38 | 0.04 | 0.00 | 0.00 | |
| Trade Payables | 6.09 | 5.02 | 4.90 | 0.61 | 0.25 | |
| Other Current Liabilities | 0.43 | 0.03 | 0.75 | 0.11 | 0.00 | |
| Short Term Provisions | 0.00 | 0.34 | 0.10 | 0.01 | 0.01 | |
| Total Current Liabilities | 9.86 | 5.77 | 5.79 | 0.73 | 0.26 | |
| Total Capital And Liabilities | 27.92 | 13.50 | 10.19 | 4.70 | 4.19 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 2.37 | 1.80 | 1.70 | 0.36 | 0.00 | |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Work-In-Progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 2.37 | 1.80 | 1.70 | 0.36 | 0.00 | |
| Non-Current Investments | 0.12 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 8.69 | 4.45 | 0.05 | 0.05 | 3.61 | |
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Assets | 11.17 | 6.25 | 1.75 | 0.41 | 3.61 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 4.10 | 0.62 | 1.29 | 0.40 | 0.10 | |
| Trade Receivables | 8.55 | 4.70 | 3.08 | 1.69 | 0.21 | |
| Cash And Cash Equivalents | 0.19 | 0.53 | 0.36 | 0.04 | 0.27 | |
| Short Term Loans And Advances | 3.91 | 1.40 | 3.71 | 2.16 | 0.00 | |
| OtherCurrentAssets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Current Assets | 16.75 | 7.25 | 8.44 | 4.29 | 0.58 | |
| Total Assets | 27.92 | 13.50 | 10.19 | 4.70 | 4.19 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 0.00 | 1.28 | 1.28 | 1.28 | 1.28 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 4.03 | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 0.12 | -- | -- | -- | -- | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
26.05.2025
Vaxtex Standalone March 2025 Net Sales at Rs 5.25 crore, up 1415.96% Y-o-Y
16.02.2024
Vaxtex Standalone December 2023 Net Sales at Rs 2.08 crore, down 81.74% Y-o-Y
20.11.2023
Vaxtex Standalone September 2023 Net Sales at Rs 4.10 crore, down 77.61% Y-o-Y
07.08.2023
Vaxtex Standalone June 2023 Net Sales at Rs 10.84 crore, down 63.06% Y-o-Y
26.05.2025
Vaxtex Standalone March 2025 Net Sales at Rs 5.25 crore, up 1415.96% Y-o-Y
16.02.2024
Vaxtex Standalone December 2023 Net Sales at Rs 2.08 crore, down 81.74% Y-o-Y
20.11.2023
Vaxtex Standalone September 2023 Net Sales at Rs 4.10 crore, down 77.61% Y-o-Y
07.08.2023
Vaxtex Standalone June 2023 Net Sales at Rs 10.84 crore, down 63.06% Y-o-Y
02.05.2024
09.04.2024
02.11.2023
03.08.2023
Adani Enterprises Q1 results: Net profit up 44% at Rs 674 crore, revenue down 38%
21.02.2019
Shaily Engineering Plastics: A disappointing Q3, but don’t overlook its long-term prospects
31.01.2019
Q3 earnings make these two stocks worthy additions to your portfolio
17.08.2018
Shaily Engineering Plastics: Home furnishing products crucial to success
17.05.2018
Shaily Engineering Plastics: Corrections could provide good entry opportunities